Biodexa Pharmaceuticals (BDRX) Payables (2013 - 2026)
Biodexa Pharmaceuticals' Payables was $2.19 million in the quarter ended Jun 30, 2026, down 14.1% from $2.55 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Payables (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Payables at Biodexa Pharmaceuticals came in at $3.41 million, down 23.8% from the prior year.
- Payables shows a five-year compound annual growth rate of 16.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Payables was $4.48 million in the year ended Dec 31, 2024 (+190.4%), $1.54 million in the year ended Dec 31, 2023 (-13.9%), $1.79 million in the year ended Dec 31, 2022 (+19.2%) and $1.5 million in the year ended Dec 31, 2021 (-4.9%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Payables since the quarter ended Dec 31, 2023.
- Compared with a year earlier, Payables was higher in two of the last four quarters, with growth averaging 40.8%.
- The best year-over-year quarter for Payables over five years was the quarter ended Dec 31, 2024 (growth of 192.2%); the worst was the quarter ended Jun 30, 2022 (a decline of 39.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.91 Bn | 1,098.50 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.69 Bn | 532.22 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.05 Bn | 476.16 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.72 Bn | 322.10 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.86 Bn | 191.25 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.51 Bn | 164.71 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Biodexa Pharmaceuticals | 4,025.62 | -23.40 Mn | - | 2.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Jun 30, 2022 | 202,601.05 |
| Dec 31, 2021 | 1.47 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Jun 30, 2020 | 7.62 Mn |
| Dec 31, 2019 | 5.89 Mn |
| Jun 30, 2019 | 4.10 Mn |
| Dec 31, 2018 | 2.67 Mn |
| Jun 30, 2018 | 5.19 Mn |
| Dec 31, 2017 | 10.76 Mn |
| Jun 30, 2017 | 9.37 Mn |
| Dec 31, 2016 | 10.33 Mn |
API Access
Biodexa Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();